全球直接侧向椎间融合术 (DLIF) 和极侧向椎间融合术 (XLIF) 植入物市场 – 行业趋势和 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球直接侧向椎间融合术 (DLIF) 和极侧向椎间融合术 (XLIF) 植入物市场 – 行业趋势和 2029 年预测

  • Medical Devices
  • Upcoming Report
  • Oct 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

>全球直接侧向椎间融合术 (DLIF) 和极侧向椎间融合术 (XLIF) 植入物市场,按适应症(退行性椎间盘疾病、脊椎滑脱、脊柱侧弯等)、最终用户(门诊手术室、医院、诊所等)划分 - 行业趋势和预测至 2029 年。

直接侧向椎间融合术 (DLIF) 和极侧向椎间融合术 (XLIF) 植入物市场

 直接侧向椎间融合术 (DLIF) 和极侧向椎间融合术 (XLIF) 植入物市场分析和规模

对于因退行性疾病、畸形或损伤导致脊柱不稳定的患者,建议进行直接侧向椎间融合术。脊柱不稳定会对脊髓或脊神经造成压力,从而导致背痛、腿痛或肌肉无力。这些体征和症状可能会扩散到臀部、臀部和腿部。

Data Bridge Market Research 分析,直接侧向椎间融合 (DLIF) 和极度侧向椎间融合 (XLIF) 植入物市场预计在 2022 年至 2029 年的预测期内将以健康的复合年增长率增长。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

直接侧向椎间融合术 (DLIF) 和极侧向椎间融合术 (XLIF) 植入物市场范围和细分      

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020(可定制为 2014 - 2019)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

适应症(退行性椎间盘疾病、脊椎滑脱、脊柱侧弯等)、最终用户(门诊手术室、医院、诊所等)

覆盖国家

北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲的其他地区。

涵盖的市场参与者

Medtronic(爱尔兰)、NuVasive, Inc.(美国)、Stryker(美国)、Medical Devices Business Services, Inc.(美国)、Zimmer Biomet(美国)、Globus Medical(美国)、Orthofix US LLC.(美国)、ATech Spine, Inc.(美国)、Osseous Surgicals(印度)、Captiva Spine, Inc.(美国)、SH Pitkar Orthotools Pvt. Ltd.(印度)、Gesco Healthcare Pvt. Ltd.(印度)、Sharma Orthopedic(印度)、Jayon Implants(印度)、Implants International(英国)

市场机会

  • 脊柱外科研发活动不断增加以及技术进步

Market Definition

The procedure known as minimally invasive extreme lateral interbody fusion (XLIF) is used to treat degenerative disc disease (DDD), degenerative spondylolisthesis and degenerative scoliosis. Unlike most mid to low back spine surgery, which involves the large muscles in the middle of your back and avoiding large muscle groups.

Direct Lateral Interbody Fusion or DLIF, is a minimally invasive surgical procedure used to treat degenerative disc disease-related leg or back pain. Unlike traditional anterior or posterior approaches to back surgery, DLIF enters the lumbar spine from the side of the patient.

Global Direct Lateral Interbody Fusion (DLIF) and eXtreme Lateral Interbody Fusion (XLIF) Implants Market Dynamics

Drivers

  • Rising usage of direct lateral interbody fusion

The direct lateral interbody fusion (DLIF), a minimally invasive lateral approach for placement of an interbody fusion device, does not require nerve root retraction or any contact with the great vessels and can lead to short operative times with little blood loss. This procedure has not been used at the lumbosacral (L5-S1) junction due to the anatomical restrictions. Lumbosacral transitional vertebrae (LSTV), a structural anomaly of the lumbosacral spine associated with low back pain, can result in a level being wrongly identified pre-operatively due to misnumbering of the vertebral levels. These are the certain factors which propel the growth of the market.

  • Rising minimally invasive procedures

Extreme lateral interbody fusion (XLIF) is a minimally invasive procedure performed through the side of the body to treat spinal disorders and relieve chronic back or leg pain that has not responded to other treatments such as steroid injections, physical therapy, and pain medication. The minimally invasive extreme lateral interbody fusion (XLIF) procedure allows the doctor to avoid major large muscle groups in the centre of the back while removing the damaged disc. The muscles are not severed, rather they are separated gently to allow the spine surgeon access to the spine and the damaged disc. After removing the damaged disc, a small plastic cage filled with bone material is placed between the vertebrae. These are the factors which propel the growth of the market.

Opportunities

  • Rising R&D activities

Rising R&D activities for spine surgery that is XLIF, which typically takes about an hour and performed under general anesthesia, the surgeon accesses the space between each spinal disc from the patient's side, rather than the front or back, sparing major back muscles, bones, and ligaments. It will provide ample opportunities for the growth of the direct lateral interbody fusion (DLIF) and eXtreme lateral interbody fusion (XLIF) implants market during the forecast period.

Restraints/Challenges

  • High cost of surgery

Unfavourable reimbursement policies of the insurance companies along with high cost of surgery and rising preferences of drugs over treatment which will acting as market restraints for the growth of the direct lateral interbody fusion (DLIF) and eXtreme lateral interbody fusion (XLIF) implants in the above mentioned forecast period.

This direct lateral interbody fusion (DLIF) and eXtreme lateral interbody fusion (XLIF) implants market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the direct lateral interbody fusion (DLIF) and eXtreme lateral interbody fusion (XLIF) implants market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Direct Lateral Interbody Fusion (DLIF) and eXtreme Lateral Interbody Fusion (XLIF) Implants Market Scope

The direct lateral interbody fusion (DLIF) and eXtreme lateral interbody fusion (XLIF) implants market is segmented on the basis of indication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indication

  • Degenerative Disc Diseases
  • Spondylolisthesis
  • Scoliosis
  • Others

  End User

  • Ambulatory Surgical Units
  • Hospitals
  • Clinics
  • Others

Direct Lateral Interbody Fusion (DLIF) and eXtreme Lateral Interbody Fusion (XLIF) Implants Market Regional Analysis/Insights

The direct lateral interbody fusion (DLIF) and eXtreme lateral interbody fusion (XLIF) implants market is analysed and market size insights and trends are provided by country, indication and end user as referenced above.

The countries covered in the direct lateral interbody fusion (DLIF) and eXtreme lateral interbody fusion (XLIF) implants market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

由于脊柱损伤发生率的不断增加、医疗设施的改善和老年人口的普遍性,北美在直接侧向椎间融合术 (DLIF) 和极度侧向椎间融合术 (XLIF) 植入物市场占据主导地位。

由于医疗旅游日益普及以及基础设施不断改善,预计亚太地区将在 2022 年至 2029 年的预测期内实现最高增长率。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

直接侧向椎间融合 (DLIF) 和极侧向椎间融合 (XLIF) 植入物市场还为您提供了详细的市场分析,包括每个国家/地区资本设备医疗支出的增长、直接侧向椎间融合 (DLIF) 和极侧向椎间融合 (XLIF) 植入物市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗监管情景的变化及其对直接侧向椎间融合 (DLIF) 和极侧向椎间融合 (XLIF) 植入物市场的影响。数据适用于 2010-2020 年的历史时期。

竞争格局和直接侧向椎间融合术 (DLIF) 和极侧向椎间融合术 (XLIF) 植入物的市场份额分析

直接侧向椎间融合术 (DLIF) 和极侧向椎间融合术 (XLIF) 植入物市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对直接侧向椎间融合术 (DLIF) 和极侧向椎间融合术 (XLIF) 植入物的关注有关。

直接侧向椎间融合术 (DLIF) 和极限侧向椎间融合术 (XLIF) 植入物市场的一些主要参与者包括:

  • 美敦力(爱尔兰)
  • NuVasive, Inc.(美国)
  • 史赛克(美国)
  • 医疗器械商业服务公司(美国)
  • Zimmer Biomet(美国)
  • Globus Medical(美国)
  • Orthofix US LLC.(美国)
  • ATech Spine, Inc.(美国)
  • 骨外科手术(印度)
  • Captiva Spine, Inc.(美国)
  • SH Pitkar Orthotools Pvt. Ltd.(印度)
  • Gesco 医疗保健列兵。有限公司(印度)
  • Sharma 骨科 (印度)
  • Jayon Implants(印度)
  • Implants International(英国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

Factors such as rising R&D activities for spine surgery, as well as technological advancement are the growth drivers of the Direct Lateral Interbody Fusion (DLIF) and eXtreme Lateral Interbody Fusion (XLIF) Implants Market.
Major companies in the Direct Lateral Interbody Fusion (DLIF) and eXtreme Lateral Interbody Fusion (XLIF) Implants Market are Medtronic (Ireland), NuVasive, Inc. (U.S.), Stryker (U.S.), Medical Devices Business Services, Inc. (U.S.), Zimmer Biomet (U.S.), Globus Medical (U.S.), Orthofix US LLC. (U.S.), ATech Spine, Inc. (U.S.), Osseous Surgicals (India), Captiva Spine, Inc. (U.S.), S. H. Pitkar Orthotools Pvt. Ltd. (India), Gesco Healthcare Pvt. Ltd. (India), Sharma Orthopedic (India), Jayon Implants (India), Implants International (U.K.) are the major companies operating in this market.
North America dominates the direct lateral interbody fusion (DLIF) and eXtreme lateral interbody fusion (XLIF) implants market due to due to the growing occurrences of spinal injuries along with improved healthcare facilities and the prevalence of the geriatric population.
Indication and end user are the factors on which the Direct Lateral Interbody Fusion (DLIF) and eXtreme Lateral Interbody Fusion (XLIF) Implants Market research is based.
Rising R&D activities are the Direct Lateral Interbody Fusion (DLIF) and eXtreme Lateral Interbody Fusion (XLIF) Implants Market Opportunities.